Inside Look at Resilience’s Latest Viral Vector Manufacturing Site

Published on: 

Sponsored Content

Designed for advanced therapy manufacturing, the Marlborough, MA facility is the first new construction at Resilience. The site will produce, rest, and release viral vector drug substance (DS) and drug product (DP), for clinical and commercial use.